Page last updated: 2024-08-17

17-alpha-hydroxyprogesterone and Pituitary Diseases

17-alpha-hydroxyprogesterone has been researched along with Pituitary Diseases in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Becu-Villalobos, D; Cristina, C; Díaz-Torga, G; González-Iglesias, A; Suarez, C1

Other Studies

1 other study(ies) available for 17-alpha-hydroxyprogesterone and Pituitary Diseases

ArticleYear
Upregulation of angiotensin II type 2 receptor expression in estrogen-induced pituitary hyperplasia.
    American journal of physiology. Endocrinology and metabolism, 2004, Volume: 286, Issue:5

    Topics: 17-alpha-Hydroxyprogesterone; Analysis of Variance; Animals; Calcium Signaling; Diethylstilbestrol; Down-Regulation; Estrogens, Non-Steroidal; Female; Hyperplasia; Pituitary Diseases; Pituitary Gland; Prolactin; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; RNA, Messenger; Up-Regulation

2004